Group for the Advancement of Psychiatry, Dallas (all authors); Department of Psychiatry, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire (Brunette); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania and Philadelphia Veterans Administration Medical Center, Philadelphia (Oslin); Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center and New York State Psychiatric Institute, New York (Dixon, Erlich, First); Department of Psychiatry, Tufts Medical Center, Boston (Adler); Optum Idaho, Boise (Berlant); Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York (Siris); Department of Psychiatry, University of Colorado School of Medicine, Aurora (Winston).
Psychiatr Serv. 2019 Dec 1;70(12):1168-1171. doi: 10.1176/appi.ps.201800582. Epub 2019 Sep 10.
The number of people with opioid use disorder and the number of overdose deaths in the United States have increased dramatically over the past 20 years. U.S. Congress passed the SUPPORT for Patients and Communities Act, which was signed into law in 2018, authorizing almost $8 billion to address the crisis. As experts in the treatment of central nervous systems disorders, psychiatrists can play a leading role in expanding treatment for people with opioid use disorder and in advocating for policy changes to support community treatment for this group.
在过去的 20 年中,美国患有阿片类药物使用障碍的人数和过量死亡人数急剧增加。美国国会通过了《患者和社区支持法案》(SUPPORT for Patients and Communities Act),并于 2018 年签署成为法律,授权投入近 80 亿美元来应对这一危机。精神科医生作为中枢神经系统疾病治疗方面的专家,可以在扩大阿片类药物使用障碍患者的治疗以及倡导支持该群体社区治疗的政策改革方面发挥主导作用。